SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Alto Ingredients, Inc. – ‘10-Q’ for 3/31/22 – ‘EX-32.1’

On:  Monday, 5/9/22, at 8:40pm ET   ·   As of:  5/10/22   ·   For:  3/31/22   ·   Accession #:  1213900-22-24981   ·   File #:  0-21467

Previous ‘10-Q’:  ‘10-Q’ on 11/12/21 for 9/30/21   ·   Next:  ‘10-Q’ on 8/9/22 for 6/30/22   ·   Latest:  ‘10-Q’ on 5/8/24 for 3/31/24   ·   3 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/10/22  Alto Ingredients, Inc.            10-Q        3/31/22   58:4.2M                                   EdgarAgents LLC/FA

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    605K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     19K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     19K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     17K 
10: R1          Document And Entity Information                     HTML     70K 
11: R2          Consolidated Balance Sheets                         HTML    143K 
12: R3          Consolidated Balance Sheets (Parentheticals)        HTML     45K 
13: R4          Consolidated Statements of Operations (Unaudited)   HTML     88K 
14: R5          Consolidated Statements of Cash Flows (Unaudited)   HTML    108K 
15: R6          Consolidated Statements of Stockholders? Equity     HTML     61K 
                (Unaudited)                                                      
16: R7          Organization and Basis of Presentation              HTML     30K 
17: R8          Acquisition of Eagle Alcohol                        HTML     30K 
18: R9          Segments                                            HTML     57K 
19: R10         Inventories                                         HTML     22K 
20: R11         Derivatives                                         HTML     36K 
21: R12         Debt                                                HTML     25K 
22: R13         Commitments and Contingencies                       HTML     22K 
23: R14         Pension Plans                                       HTML     25K 
24: R15         Fair Value Measurements.                            HTML     71K 
25: R16         Earnings Per Share                                  HTML     40K 
26: R17         Accounting Policies, by Policy (Policies)           HTML     43K 
27: R18         Acquisition of Eagle Alcohol (Tables)               HTML     28K 
28: R19         Segments (Tables)                                   HTML     55K 
29: R20         Inventories (Tables)                                HTML     22K 
30: R21         Derivatives (Tables)                                HTML     35K 
31: R22         Debt (Tables)                                       HTML     21K 
32: R23         Fair Value Measurements. (Tables)                   HTML     66K 
33: R24         Earnings Per Share (Tables)                         HTML     38K 
34: R25         Organization and Basis of Presentation (Details)    HTML     31K 
35: R26         Acquisition of Eagle Alcohol (Details)              HTML     44K 
36: R27         Acquisition of Eagle Alcohol (Details) - Schedule   HTML     25K 
                of pro forma combined financial information                      
                assuming the acquisition occurred                                
37: R28         Acquisition of Eagle Alcohol (Details) - Schedule   HTML     54K 
                of preliminary purchase price allocation                         
38: R29         Segments (Details)                                  HTML     18K 
39: R30         Segments (Details) - Schedule of financial data     HTML     86K 
                for operating segments                                           
40: R31         Segments (Details) - Schedule of assets by          HTML     34K 
                operating segments                                               
41: R32         Inventories (Details)                               HTML     18K 
42: R33         Inventories (Details) - Schedule of inventories     HTML     28K 
43: R34         Derivatives (Details)                               HTML     18K 
44: R35         Derivatives (Details) - Schedule of derivatives     HTML     26K 
                not designated as hedging instruments                            
45: R36         Derivatives (Details) - Schedule of recognized      HTML     26K 
                gains (losses) for derivatives                                   
46: R37         Debt (Details)                                      HTML     18K 
47: R38         Debt (Details) - Schedule of long-term borrowings   HTML     25K 
48: R39         Commitments and Contingencies (Details)             HTML     39K 
49: R40         Pension Plans (Details)                             HTML     45K 
50: R41         Fair Value Measurements. (Details)                  HTML     18K 
51: R42         Fair Value Measurements. (Details) - Schedule of    HTML     72K 
                recurring and nonrecurring fair value measurements               
52: R43         Earnings Per Share (Details)                        HTML     23K 
53: R44         Earnings Per Share (Details) - Schedule of compute  HTML     62K 
                basic and diluted earnings per share                             
56: XML         IDEA XML File -- Filing Summary                      XML    101K 
54: XML         XBRL Instance -- f10q0322_altoingredi_htm            XML    901K 
55: EXCEL       IDEA Workbook of Financial Reports                  XLSX     59K 
 6: EX-101.CAL  XBRL Calculations -- alto-20220331_cal               XML     97K 
 7: EX-101.DEF  XBRL Definitions -- alto-20220331_def                XML    490K 
 8: EX-101.LAB  XBRL Labels -- alto-20220331_lab                     XML    971K 
 9: EX-101.PRE  XBRL Presentations -- alto-20220331_pre              XML    483K 
 5: EX-101.SCH  XBRL Schema -- alto-20220331                         XSD    121K 
57: JSON        XBRL Instance as JSON Data -- MetaLinks              304±   400K 
58: ZIP         XBRL Zipped Folder -- 0001213900-22-024981-xbrl      Zip    145K 


‘EX-32.1’   —   Certification — §906 – SOA’02


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



EXHIBIT 32.1

 

CERTIFICATIONS OF
CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report on Form 10-Q of Alto Ingredients, Inc. (the “Company”) for the three months ended March 31, 2022 (the “Report”), the undersigned hereby certify in their capacities as Chief Executive Officer and Chief Financial Officer of the Company, respectively, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

1. the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated:  May 9, 2022 By:  /s/ MICHAEL D. KANDRIS
    Michael D. Kandris
    President and Chief Executive Officer
    (Principal Executive Officer)
     
Dated:  May 9, 2022 By: /s/ BRYON T. MCGREGOR
    Bryon T. McGregor
    Chief Financial Officer
    (Principal Financial Officer)

 

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signatures that appear in typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

 


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
Filed as of:5/10/22
Filed on:5/9/228-K
For Period end:3/31/22
 List all Filings 


3 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

12/13/22  Alto Ingredients, Inc.            424B3      12/12/22    1:190K                                   EdgarAgents LLC/FA
11/29/22  Alto Ingredients, Inc.            S-3                    4:290K                                   EdgarAgents LLC/FA
 7/06/22  Alto Ingredients, Inc.            S-8         7/06/22    5:266K                                   EdgarAgents LLC/FA
Top
Filing Submission 0001213900-22-024981   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., May 14, 8:20:13.1pm ET